Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Qiagen NV QGEN

Technology Scientific & Technical Instruments
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic... see more

Recent & Breaking News (NYSE:QGEN)

QIAGEN announces Form 20-F annual report filing for 2023 results

GlobeNewswire March 11, 2024

QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery

GlobeNewswire February 27, 2024

QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification

GlobeNewswire February 27, 2024

QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification

GlobeNewswire February 15, 2024

QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability

GlobeNewswire February 6, 2024

QIAGEN announces partnership with Penn State University to advance microbiome sciences

GlobeNewswire January 25, 2024

QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million

GlobeNewswire January 18, 2024

QIAGEN N.V. to release results for Q4 2023 and hold webcast

GlobeNewswire January 11, 2024

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

GlobeNewswire January 8, 2024

QIAGEN announces plans to return approximately $300 million to shareholders

GlobeNewswire January 7, 2024

QIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics business

GlobeNewswire January 4, 2024

QIAGEN expands business in Middle East with new regional headquarters and major projects

GlobeNewswire January 3, 2024

DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy

GlobeNewswire November 30, 2023

QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolation

GlobeNewswire November 15, 2023

QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customers

GlobeNewswire November 9, 2023

QIAGEN launches complete Sample to Insight workflow for microbiome research

GlobeNewswire November 6, 2023

QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System

GlobeNewswire November 2, 2023

QIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth in non-COVID products and adjusted EPS of $0.50 CER

GlobeNewswire October 30, 2023

QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer

GlobeNewswire October 26, 2023

QIAGEN N.V. to release results for Q3 2023 and hold webcast

GlobeNewswire October 9, 2023